tm logo
NCOUNTER SPRINT
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 29 Jun 2022

Last Applicant/ Owned by

40 MANNING ROAD

BILLERICA

MA

01821

Serial Number

86357017 filed on 04th Aug 2014

Registration Number

5124745 registered on 17th Jan 2017

in the Principal Register

Correspondent Address

Alyssa M. Worsham

Alyssa M. Worsham WILSON SONSINI GOODRICH & ROSATI

PALO ALTO, CA 94304-1050

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

NCOUNTER SPRINT

diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, mic Read More

Classification Information


Class [009]
Computer & Software Products & Electrical & Scientific Products


computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadable


First Use Date in General

31st May 2015

First Use Date in Commerce

31st May 2015

Class [005]
Pharmaceutical Products


diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care, namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes


First Use Date in General

31st Aug 2015

First Use Date in Commerce

31st Aug 2015

Class [001]
Chemical Products


diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors, namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing


First Use Date in General

31st Aug 2015

First Use Date in Commerce

31st Aug 2015

Mark Details


Serial Number

No 86357017

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 31353-TM1022

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Jul 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29th Jun 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
29th Jun 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
29th Jun 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25th Jan 2022TEAS SECTION 8 & 15 RECEIVED
17th Jan 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
18th Mar 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
17th Jan 2017REGISTERED-PRINCIPAL REGISTER
13th Dec 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
12th Dec 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED